Equities

Mercator Medical SA

Mercator Medical SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)41.90
  • Today's Change0.00 / 0.00%
  • Shares traded1.30k
  • 1 Year change+0.10%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mercator Medical SA is a Poland-based company engaged in medical supplies industry. The Company manufactures medical gloves and distributes disposable medical materials. It produces medical, latex, synthetic, surgical, diagnostic sterile, examination and protective and household gloves. Its dressing products line includes gauze dressing products, non-woven fabric dressing, medical adhesive tapes, surgical dressing, among others. In addition, the Company provides drapes such as bed sheets, sets, as well as apparel, including caps, masks, gowns, among others. It operates through subsidiaries: Mercator Medical Kft, Mercator Medical srl, Merkator Medikal TOB, Mercator Medical (Thailand) Ltd and VIVOFT LLP.

  • Revenue in PLN (TTM)469.82m
  • Net income in PLN-232.16m
  • Incorporated2001
  • Employees1.29k
  • Location
    Mercator Medical SAHeleny Modrzejewskiej 30KRAKOW 31-327PolandPOL
  • Phone+48 126655400
  • Fax+48 126655415
  • Websitehttps://mercatormedical.eu/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SDI Group PLC343.34m8.10m284.76m489.0035.571.299.560.82940.01520.01520.65280.41740.79582.086.29139,206.501.938.832.3411.4363.3464.572.4310.641.145.860.33110.0036.0936.05-48.6819.1111.86--
Inspecs Group PLC1.03bn-5.03m292.30m1.67k--0.55984.810.2851-0.0109-0.01091.941.020.88642.248.68121,513.40-0.4347-1.48-0.6975-2.1550.9448.50-0.4904-1.970.86771.540.375--1.1636.4584.22--51.04--
Optomed Oyj65.20m-19.17m321.77m114.00--3.59--4.93-0.2695-0.26950.92111.150.50021.674.92132,456.10-14.70-12.95-17.72-15.9067.8365.69-29.40-27.842.04-7.290.1926--3.003.4718.84--7.26--
OssDsign AB41.46m-48.24m333.57m----3.84--8.05-1.74-1.741.522.410.34086.546.19---39.65-38.80-44.90-44.7274.5872.29-116.35-203.054.15-30.390.0132--96.8253.26-31.30---60.35--
Mentice AB101.14m-1.04m341.21m114.00--5.8137.083.37-0.1094-0.109410.896.220.83492.403.202,400,079.00-0.8596-7.69-1.69-13.0786.3983.67-1.03-10.001.01--0.0567--25.5411.7490.81---10.83--
Integrum AB35.56m3.05m365.75m34.00124.386.9695.4310.290.4470.4475.197.990.59180.58593.83--5.08-6.655.65-7.9586.8081.528.58-11.193.04-4.280.0462--33.2937.39-117.50--86.42--
Carmat SA3.86m-234.75m396.17m177.00------102.51-2.25-2.250.0369-0.38170.01231.580.20295,000.00-74.73-76.92-89.51-93.77-3,232.74---6,074.19-9,203.392.81-14.251.18---84.52--13.24---10.97--
Mercator Medical SA469.82m-232.16m446.12m1.29k--0.4542--0.9495-23.80-23.8048.7292.240.41252.545.35363,078.80-20.7529.67-22.1136.780.488538.55-50.3023.595.67-40.080.0062.49-68.5912.52-142.43--8.36--
C Rad AB156.96m17.00m470.72m84.0028.524.6423.193.001.361.3612.558.341.144.453.82--12.415.8717.408.0645.4543.0110.865.602.48287.500.00640.0040.9117.43516.3916.82----
Meditera Tibbi Mlzm Sny Tcrt AS180.55m3.22m473.13m728.00147.132.5547.892.620.21740.217412.2012.530.76782.925.311,994,873.001.379.371.5911.5444.3343.511.789.852.83--0.0552181.79-8.9948.75-77.3815.68----
Oncosem Onkolojik Sistemlr Sny v Tcrt AS29.90m-9.92m515.64m324.00--17.90--17.24-3.44-3.4410.159.720.69932.473.93742,302.40-23.20---31.86--14.88---33.18--1.30--0.2087---17.90---284.37------
Bastide Le Confort Medical SA2.26bn27.28m559.45m3.55k24.141.601.580.24760.72990.77265.5711.020.79555.446.90147,580.701.842.492.663.5250.5448.822.313.050.8111.920.8391--8.4811.9411.2417.556.98--
ADDvise Group AB (publ)545.58m40.96m614.66m620.0023.793.327.421.130.58640.58647.844.200.55066.735.522,365,224.004.143.725.174.7747.6348.957.515.891.092.990.66080.940544.3038.6227.62--30.35--
Data as of Apr 26 2024. Currency figures normalised to Mercator Medical SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

1.33%Per cent of shares held by top holders
HolderShares% Held
Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 30 Jun 2023121.59k1.24%
Allianz Polska TFI SAas of 31 Dec 20236.08k0.06%
Dimensional Fund Advisors Ltd.as of 30 Nov 20231.31k0.01%
Dimensional Fund Advisors LPas of 31 Jan 20241.16k0.01%
PKO TFI SAas of 29 Dec 2023218.000.00%
American Century Investment Management, Inc.as of 29 Feb 2024146.000.00%
IPOPEMA TFI SAas of 30 Jun 20230.000.00%
Pekao TFI SAas of 30 Jun 20210.000.00%
More ▼
Data from 30 Jun 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.